Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Announcement on Resolutions of the 2025 Annual General Meeting

May 16, 2026 · Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange

Announcement on Resolutions of the 2025 Annual General Meeting

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Hinova Pharmaceuticals, Inc. Class A

Announcement on Voluntary Disclosure of Interim Analysis Results Obtained from Phase IIa Clinical Trial of the Drug HP515 for Treating Metabolic-Associated Steatohepatitis (MASH)Apr 28
Notice on Convening the 2025 Annual General MeetingApr 25
Announcement on Change of Sponsor RepresentativeApr 21

All Hinova Pharmaceuticals, Inc. Class A news releases